2D, 3D-QSAR study and docking of vascular endothelial growth factor receptor 3 (VEGFR3) inhibitors for potential treatment of retinoblastoma

Background: Retinoblastoma is currently the most common malignant tumor seen in newborns and children’s eyes worldwide, posing a life-threatening hazard. Chemotherapy is an integral part of retinoblastoma treatment. However, the chemotherapeutic agents used in clinics often lead to drug resistance....

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Rui, Gao, Liyu, Li, Guoqi, Wang, Shuqiang, Zhao, Yangzhong, Wang, Haitong, Liu, Jianwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119426/
https://www.ncbi.nlm.nih.gov/pubmed/37089961
http://dx.doi.org/10.3389/fphar.2023.1177282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119426/
https://www.ncbi.nlm.nih.gov/pubmed/37089961
http://dx.doi.org/10.3389/fphar.2023.1177282

Ejemplares similares